The liver’s unique architecture is characterized by its metabolic zonation, where hepatocytes in distinct regions—the periportal (portal vein, PV) and pericentral (central vein, CV) zones—exhibit specialized functions directed by region-specific signaling pathways. Wnt/β-catenin signaling predominantly governs the pericentral region, while Notch signaling pathways drive periportal activities. These discrete signaling environments enable the liver to efficiently regulate complex metabolic, synthetic, and detoxification processes that are vital for systemic homeostasis.

Leveraging extensive transcriptomic analyses from both human and rodent liver tissues, the team meticulously mapped the spatial distribution of signaling pathways instrumental in liver zonation. This molecular blueprint revealed that genes associated with Wnt ligand WNT2 and Notch ligand DLL4 are expressed predominately in endothelial cells within their respective zones, forming the basis for generating engineered microenvironments. Confirmation through immunofluorescence and immunohistochemical studies on human liver sections validated these spatial patterns, providing a firm biological foundation to reconstruct zonal heterogeneity in vitro using genetically modified cell types.

Capitalizing on these insights, researchers developed two transgenic SK-Hep1 endothelial cell lines engineered to overexpress either WNT2 or DLL4. When co-cultured with primary human hepatocytes, these engineered endothelial cells orchestrated region-specific hepatocyte differentiation. The WNT2-expressing endothelial cells induced hepatocytes with enhanced cytochrome P450 enzyme activity, mimicking pericentral functions critical for xenobiotic metabolism. Conversely, DLL4-expressing cells promoted cholangiocyte-like phenotypes and enhanced bile transport characteristic of periportal zones, thereby recapitulating the spatial functional heterogeneity of the native liver.

The dynamic interplay within these organoids also enabled hepatic progenitor cells to bifurcate into hepatocyte- and cholangiocyte-dominant lineages, emulating the developmental plasticity governed by microenvironmental cues in the liver. This bifurcation is pivotal for generating organoids that not only function accurately but also reflect the liver’s developmental and regenerative biology, which has vast implications for modeling liver diseases and therapeutic interventions.

In pharmacological assays, the platform exhibited remarkable sensitivity and specificity. Upon exposure to acetaminophen, an established hepatotoxin, the WNT2 co-cultured organoids demonstrated heightened oxidative stress susceptibility coupled with a robust regenerative response upon drug withdrawal. Such findings mirror clinical hepatotoxicity and recovery patterns, positioning this organoid system as a superior model for drug-induced liver injury studies. Meanwhile, DLL4 co-cultured organoids effectively replicated cholestatic injury phenotypes, including impaired bile clearance following drug treatments, which were reversible upon administration of choleretic agents, showcasing its utility in modeling periportal pathologies.

Further pushing the envelope, the team harnessed state-of-the-art 3D bioprinting technology to spatially arrange endothelial and parenchymal cells into a biomimetic liver lobule architecture. This printed construct elegantly recapitulates the liver’s zonal organization, demonstrating region-specific expression of hallmark functional proteins such as glutamine synthetase in pericentral-mimicking zones and multidrug resistance protein 2 (MRP2) along with increased albumin and urea secretion. The 3D architecture closely mimics in vivo tissue ultrastructure and function, which is critical for accurate disease modeling and drug toxicity testing.

Intriguingly, the engineered lobule exhibited selective vulnerability akin to the native liver. The pericentral-mimicking zones showed heightened sensitivity to acetaminophen-induced injury, faithfully reproducing the hepatotoxic patterns observed clinically. This spatially resolved injury response highlights the model’s capacity to dissect zonal-specific pathophysiology, a feature that has been unattainable with conventional culture systems.

This breakthrough represents a significant leap in liver bioengineering by integrating gene-engineered endothelial microenvironment cues with sophisticated 3D bioprinting. The resultant platform stands out as a physiologically relevant, spatially complex system capable of emulating the liver’s functional heterogeneity and its nuanced injury responses. Its application promises to refine preclinical drug screening pipelines, enhancing prediction accuracy for hepatotoxicity and therapeutic efficacy.

Moreover, the platform opens avenues for personalized medicine in hepatology by enabling patient-specific modeling of liver diseases, including chronic liver conditions, metabolic disorders, and drug-induced liver injuries. Implementing such organoids in precision medicine could revolutionize how liver disease progression and treatment responses are studied and managed, reducing reliance on animal models and improving translational relevance.

The collaborative effort also emphasizes the critical role of endothelial heterogeneity in orchestrating liver function and regeneration, an often-overlooked aspect in traditional liver models. By recapitulating endothelial-mediated spatial signaling, this system affords a more faithful representation of the liver’s microenvironment, offering a valuable tool for studying vascular contributions to liver health and disease.

This pioneering work from Tsinghua University’s multidisciplinary team aligns with the cutting-edge trajectory of organoid technology, marrying genetic engineering, vascular biology, and bioprinting to recreate one of the body’s most metabolically complex organs. As such, it sets a new benchmark for organoid fidelity and functional sophistication, likely inspiring a paradigm shift in liver research methodologies.

Taken together, these innovations underscore the transformative potential of engineered organoids in research and medicine. Such platforms not only promise to expedite drug development by providing reliable human tissue surrogates but also have profound implications for regenerative therapies and the modeling of liver pathologies, ultimately propelling hepatology into a new era of precision biomedical sciences.

Subject of Research: Liver organoid development mimicking region-specific liver zonation for disease modeling and drug evaluation.

Article Title: Construction of Region-Specific Liver Organoid and Fabrication of Hierarchical Functional Liver Lobule for Liver Disease Modeling and Drug Evaluation.

Web References: http://dx.doi.org/10.1016/j.scib.2025.07.021

Image Credits: ©Science China Press

Keywords: liver organoid, metabolic zonation, Wnt signaling, Notch signaling, 3D bioprinting, hepatocyte differentiation, liver disease modeling, drug toxicity, liver microenvironment, endothelial heterogeneity, acetaminophen-induced injury, cholestasis.

The study focuses on the ability of advanced liver organoids to replicate the complex internal structures typically seen in actual human tissue, shedding light on the potential for these organoids to serve as models for human biology and disease. With the critical role that blood vessels play in organ function, the significance of this research extends far beyond academic exploration. By enabling the formation of functional liver tissue that can interact closely with its vascular components, this development could revolutionize how we approach therapy for various medical conditions.

Over the years, researchers have endeavored to construct functional organoids that mimic the natural architecture of organs. The journey has involved extensive experimentation and refinement of techniques, and this recent breakthrough underscores just how challenging these efforts can be. The innovative methods developed by the Cincinnati Children’s research team involved coaxing sinusoidal cells to migrate and form vascular structures while ensuring that they remained functional and integrated with liver tissue. These intricate interactions are vital, as they capture the necessary cellular exchanges that occur during true organ development.

Crucially, the research illustrates the potential for organoids to model human disease states accurately. By performing this work in vitro, researchers now have a platform to explore the pathophysiology of various liver diseases, including hemophilia A, in a setting that closely simulates the human condition. This is particularly noteworthy given the increasing prevalence of liver-related diseases worldwide, necessitating innovative research approaches to develop more effective treatments.

The detailed methodology employed in the study is as fascinating as the results. Scientists started with induced pluripotent stem cells (iPSCs) derived from human cells. By harnessing these versatile cells, which can differentiate into any cell type, the research team successfully guided their development into liver sinusoidal endothelial progenitors (iLSEP). The application of an inverted multilayered air-liquid interface (IMALI) culture system proved instrumental, facilitating the structured organization of these progenitors into functioning vascular networks.

One of the pivotal findings of this research is the realization that the progenitor cells derived specifically from the liver context offer distinct advantages over other sources. Unlike traditional methods that utilized fully committed endothelial cells, which may not integrate seamlessly into organoid structures, the liver-specific progenitor cells exhibited enhanced functionality and compatibility with the overall tissue environment. This is a crucial insight that paves the way for more effective applications in regenerative medicine.

Moreover, the study’s success in generating perfused blood vessels emphasizes the potential therapeutic implications of these findings. The organoids displayed sinusoid-like features, allowing the blood flow necessary for nutrient exchange and cellular communication. As a demonstration of functional efficacy, the research also revealed that the developed organoids can produce essential blood coagulation factors, including Factor VIII, which is particularly relevant for treating hemophilia A—a condition affecting thousands of individuals who face significant health challenges due to their inability to form blood clots properly.

The prospect of utilizing these organoids as a source of coagulation factors presents new avenues for treatment methodologies. The ability to cultivate and harvest these factors from organoids could address current limitations surrounding commercially available clotting factor therapies, particularly for patients who have developed inhibitors to traditional treatments. Should these organoids prove viable for large-scale production, they could represent a transformative shift in treatment accessibility for individuals with hemophilia or other coagulation disorders.

Further implications extend to patients suffering from liver failure, as these organoids could provide a vital source of coagulation factors, enhancing their resilience during surgical interventions and other critical scenarios. The regenerative capabilities of these organoids indicate potential pathways for developing therapeutic solutions that facilitate liver recovery, repositioning the field toward restorative approaches rather than solely relying on transplant options.

With cutting-edge research continually pushing the envelope of what is possible in organoid technology, this advancement serves as a beacon of hope for patients dealing with debilitating conditions. As investigators at Cincinnati Children’s continue to refine their techniques and explore organoid capabilities, the scientific community watches with keen anticipation for the next steps in this promising field.

This study represents yet another leap toward creating functional tissue constructs that could mimic the complexities of human organ systems while providing the benefits of in vitro experimentation. By unraveling the fundamental processes governing organ development and cellular interactions, the researchers create opportunities for significant advancements in therapeutic applications.

As they look ahead, researchers must contend with the challenges of ensuring that these organoids remain functional long-term while also investigating how to effectively integrate them into broader treatment frameworks. The balance of replicating natural development while facilitating human applications will define the contours of this exciting area of biomedical research.

In summary, the creation of liver organoids with the capacity to form their own blood vessels signifies a transformative step forward in the quest for effective treatment options for liver diseases, particularly hemophilia. By marrying the intricacies of biological development with innovative research methodologies, scientists are opening new doors to solving prevailing medical challenges.

Subject of Research: Cells
Article Title: Self-organization of sinusoidal vessels in pluripotent stem cell-derived human liver bud organoids
News Publication Date: 25-Jun-2025
Web References: Link to source
References: Nature Biomedical Engineering
Image Credits: Credit: Cincinnati Children’s

Keywords